Home >> Stock Forums >> biopharm risk stock ... PTN

biopharm risk stock ... PTN

squarepusher said: "A biopharmaceutical company focused on discovering and developing melanocortin-based (MCR) therapeutics. The company is currently conducting clinical investigations with PT-141, a MCR agonist, for the treatment of male and female sexual dysfunction. seems to have taken huge hits recently [url]http://finance.yahoo.com/q/bc?s=PTN&t=3m&l=on&z=m&q=l&c=[/url] could be a nice gainer , set your stops real tight on this one"

Cryogenix said: "Last: .34 (high .37, low .32 - VOL 1,176,000) Very interesting situation. The price consolidates for nearly 10 months at roughly 1.95, then downspikes 1.50 on FDA concerns. With a target of .50, it's still not all that great of a deal, even though their financials don't look all that bad. Setbacks are never good for biotechs... Volume increased nicely this last session and it squeezed out a couple of pennies, so that's promising, but not a sign that all is well at this level. Unless they have spectacular news, I don't see any reason for this to make a climb beyond .40, especially given the hammering it took, the low target and the setbacks. I'm not sure I see the motivation for traders to get into a position with this thing. Time will tell..."